Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma

被引:25
作者
Hansen, T
Unger, RE
Gaumann, A
Hundorf, I
Maurer, J
Kirkpatrick, CJ
Kriegsmann, J
机构
[1] Univ Mainz, Inst Pathol, D-55101 Mainz, Germany
[2] Univ Mainz, Dept Otorhinolaryngol, D-55101 Mainz, Germany
关键词
bone degradation; cathepsin K; cholesteatoma; osteoclasts;
D O I
10.1038/modpathol.3880465
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cholesteatoma is a nonneoplastic lesion of the middle ear space or mastoid that is histologically characterized by a progressive bone erosion of the ossicles and surrounding bone. Several matrix-degrading enzymes have been Implicated as mediators of this bone erosion. Because the novel cysteine proteinase cathepsin K has been shown to play a central role in bone resorption, we examined the expression of this enzyme in tissue specimens of cholesteatoma. Tissue specimens of 9 patients with cholesteatoma were obtained during middle-ear surgery. Expression of cathepsin K mRNA was determined by RT-PCR using specific primers. Immunohistochemical analysis of cathepsin K protein expression in tissue sections was performed by using the streptavidin-alkaline phosphatase technique. Expression of both cathepsin K mRNA and protein was detected in areas affected by cholesteatoma, whereas specimens of nonaffected. ear cartilage and surrounding tissue were not positive. In addition, cathepsin K was detected in numerous multinucleated giant cells, particularly osteoclasts, at the site of bone degradation. In contrast, keratinized squamous epithelium was negative for cathepsin K. These data demonstrate that the matrix-degrading cysteine proteinase cathepsin K may be involved in bone erosion in cholesteatoma. Strong expression of this collagenolytic enzyme in osteoclasts suggests that these cells are mainly involved in cathepsin K-mediated bone destruction.
引用
收藏
页码:1226 / 1231
页数:6
相关论文
共 36 条
[1]   LOCALIZATION OF COLLAGENASE IN HUMAN MIDDLE-EAR CHOLESTEATOMA [J].
ABRAMSON, M ;
HUANG, CC .
LARYNGOSCOPE, 1977, 87 (05) :771-791
[2]   Clinical and biochemical studies of bone destruction in cholesteatoma [J].
Amar, MS ;
Wishahi, HF ;
Zakhary, MM .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1996, 110 (06) :534-539
[3]  
Blair HC, 2000, J CELL BIOCHEM, V78, P627, DOI 10.1002/1097-4644(20000915)78:4<627::AID-JCB12>3.0.CO
[4]  
2-3
[5]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[6]  
Bühling F, 2000, ADV EXP MED BIOL, V477, P281
[7]   Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma [J].
Bujia, J ;
Kim, C ;
Boyle, D ;
Hammer, C ;
Firestein, G ;
Kastenbauer, E .
LARYNGOSCOPE, 1996, 106 (02) :217-220
[10]  
Dodds RA, 1999, ARTHRITIS RHEUM, V42, P1588, DOI 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO